 |
|
Nasal Mucosa in Pancreatic Cystic Fibrosis
Stanley L. Magid, MD;
C. C. Smith, MD;
David A. Dolowitz, MD
Arch Otolaryngol. 1967;86(2):212-216.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
UNDERSTANDING of the nasal respiratory changes in cystic fibrosis of the pancreas has developed slowly during the past 20 years. At present this area has received little attention and offers much information to the investigator. An attempt is made to compare the nasal polyps of cystic fibrosis patients to normal nasal respiratory mucosa using various parameters for comparison.
Cystic fibrosis of the pancreas was proposed as a clinical entity by D. H. Anderson in 1938.1 The lack of a physiological mechanism that could explain the specific clinical findings delayed the recognition of the disease until the correlation of the characteristic pancreatic lesions substantiated the disease entity.
The disease usually is manifested soon after birth by gastrointestinal and cardiopulmonary symptomatology.
Gastrointestinal symptoms consist of foul, bulky stools, frequent diarrhea, poor weight gain, frequent episodes of colic. The bronchopulmonary changes consist of various degrees of nasal congestion associated with chronic sinusitis
. . . [Full Text PDF of this Article]
Author Affiliations
Salt Lake City
From the departments of surgery (otolaryngology) (Drs. Magid and Dolowitz) and radiology (Dr. Smith), University of Utah Medical School, Salt Lake City.
Footnotes
Accepted for publication Jan 25, 1967.
Read before the Pacific Coast Oto-Ophthalmological Society, Colorado Springs, Colo, May 12, 1966.
Reprint requests to 2000 S Ninth E, Salt Lake City 84105 (Dr. Dolowitz).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
